Phase IV Clinical Trial of an Influenza Split Vaccine Anflu

Summary

To evaluate the safety and immunogenicity of the three consecutive lots of an seasonal split influenza vaccine Anflu in adults, a randomized, double-blind and controlled clinical trial was conducted in 560 subjects in Tianjin City of China.

Timeline

Start

2007-09

Primary completion

—

Completion

2007-11

Drugs

Indications